BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Makucell Announces Key Scientific Findings for Its Proprietary Technology, Asymmtate™


7/17/2012 10:23:08 AM

SCOTTSDALE, Ariz. & LOS ANGELES--(BUSINESS WIRE)--Makucell, Inc., a pioneering regenerative biotechnology company dedicated to the development, manufacture and distribution of non-prescription products formulated to reduce the impact of aging on the skin’s appearance announces key scientific findings for its proprietary technology, Asymmtate™. Asymmtate™ is a cosmetic ingredient that influences the gene co-activator choice used by ß-catenin to encourage skin stem cell differentiation. The study’s results showed that application of a cream containing Asymmtate™ is associated with down-regulation of the gene expression of pro-opiomelanocortin (“POMC”) and up-regulation of melanocortin receptor (“MCR1”) in human skin compared to the base cream. Aging, especially photo-aging, causes differences in the distribution and activity of melanocytes leading to mottled pigmentation, freckles and lentigines (liver spots). The study results suggest that using a cream with Asymmtate™ may reverse gene expression changes associated with aging skin and with lentigines. Makucell’s Vice President and Chief Medical Officer, Mark V. Dahl, MD, will be presenting the poster at the Cosmetic Boot Camp in Colorado Springs, Colorado, which takes place July 19 through 21, 2012.

Read at BioSpace.com

Makucell
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES